Jasper Therapeutics Inc.
(JSPR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Operating Expenses | 12,082 | 10,079 | 8,418 | 6,254 | 14,119 |
| Operating Income | -12,082 | -10,079 | -8,418 | -6,254 | -14,119 |
| Other Income | 3,025 | 6,667 | 4 | -3,500 | -4,779 |
| Pre-tax Income | -9,057 | -3,412 | -8,414 | -9,754 | -18,897 |
| Net Income Continuous | -9,057 | -3,412 | -8,414 | -9,754 | -18,838 |
| Net Income | $-9,057 | $-3,412 | $-8,414 | $-9,754 | $-18,838 |
| EPS Basic Total Ops | -2.50 | -6.90 | -40.00 | -49.20 | 17.70 |
| EPS Basic Continuous Ops | -2.50 | -6.87 | -39.97 | -49.24 | 17.73 |
| EPS Diluted Total Ops | -2.50 | -6.90 | -40.00 | -49.20 | 17.70 |
| EPS Diluted Continuous Ops | -2.50 | -6.87 | -39.97 | -49.24 | 17.73 |
| EBITDA(a) | $-11,888 | $-9,947 | $-8,389 | $-6,232 | $-14,119 |